8月21日三星医疗发布2025半年度分配预案，拟10派4.85元（含税），预计派现金额合计为6.79亿元。派 现额占净利润比例为55.20%，这是公司上市以来，累计第14次派现。 公司上市以来历次分配方案一览 | 日期 | 分配方案 | 派现金额合计（亿元） | 股息率（%） | | --- | --- | --- | --- | | 2025.06.30 | 10派4.85元（含税） | 6.79 | 1.88 | | 2024.12.31 | 10派8.9元（含税） | 12.46 | 2.91 | | 2023.12.31 | 10派6.5元（含税） | 9.10 | 4.25 | | 2022.12.31 | 10派3.5元（含税） | 4.94 | 2.94 | | 2021.12.31 | 10派3.2元（含税） | 4.51 | 2.23 | | 2020.12.31 | 10派3.5元（含税） | 4.85 | 4.65 | | 2019.12.31 | 10派2.1元（含税） | 2.91 | 3.16 | | 2018.12.31 | 10派3元（含税） | 4.16 | 4.08 | | ...

Group 1 - Xiamen Tungsten's revenue for the first half of 2025 reached 19.178 billion yuan, an increase of 11.75% year-on-year [1] - Xiamen Tungsten's net profit attributable to shareholders decreased by 4.37% year-on-year to 972 million yuan [1] - Xiamen Tungsten plans to distribute a cash dividend of 1.84 yuan per 10 shares [1] Group 2 - Sinopec's revenue for the first half of 2025 was 1.41 trillion yuan, a decrease of 10.6% year-on-year [1][2] - Sinopec's net profit attributable to shareholders fell by 39.8% year-on-year to 21.483 billion yuan [1][2] - Sinopec's basic earnings per share were 0.177 yuan [1] Group 3 - Xinhua Department Store's revenue for the first half of 2025 was 3.254 billion yuan, a decrease of 0.99% year-on-year [3][4] - Xinhua Department Store's net profit attributable to shareholders decreased by 2.52% year-on-year to 86.08 million yuan [3][4] - Xinhua Department Store plans to distribute a cash dividend of 1 yuan per 10 shares [3] Group 4 - Huaqin Technology's revenue for the first half of 2025 reached 516 million yuan, an increase of 6.44% year-on-year [5][6] - Huaqin Technology's net profit attributable to shareholders decreased by 32.45% year-on-year to 146 million yuan [5][6] - Huaqin Technology plans to distribute a cash dividend of 1.3 yuan per 10 shares [5] Group 5 - Tianhao Energy's revenue for the first half of 2025 was 1.372 billion yuan, a decrease of 32.15% year-on-year [7] - Tianhao Energy's net profit attributable to shareholders decreased by 32.08% year-on-year to 69.01 million yuan [7] - Tianhao Energy's basic earnings per share were 0.0798 yuan [7] Group 6 - Wanliyang's revenue for the first half of 2025 reached 2.812 billion yuan, an increase of 2.69% year-on-year [8][9] - Wanliyang's net profit attributable to shareholders increased by 50.24% year-on-year to 277 million yuan [8][9] - Wanliyang's basic earnings per share were 0.21 yuan [8] Group 7 - Kede CNC's revenue for the first half of 2025 was 295 million yuan, an increase of 15.24% year-on-year [10] - Kede CNC's net profit attributable to shareholders increased by 1.27% year-on-year to 49.06 million yuan [10] - Kede CNC's basic earnings per share were 0.4582 yuan [10] Group 8 - Saifutian's revenue for the first half of 2025 reached 1.06 billion yuan, an increase of 62.41% year-on-year [11] - Saifutian achieved a net profit of 3.08 million yuan, recovering from a loss of 12.49 million yuan in the previous year [11] - Saifutian's basic earnings per share were 0.01 yuan [11] Group 9 - Funeng's revenue for the first half of 2025 was 6.369 billion yuan, a decrease of 4.44% year-on-year [13][14] - Funeng's net profit attributable to shareholders increased by 12.48% year-on-year to 1.337 billion yuan [13][14] - Funeng plans to distribute a cash dividend of 0.73 yuan per 10 shares [13] Group 10 - Ningbo Shipping reported a net loss of 39.23 million yuan for the first half of 2025 [15][16] - Ningbo Shipping's revenue for the first half of 2025 was 1.157 billion yuan, an increase of 11.33% year-on-year [15][16] - Ningbo Shipping's basic earnings per share were a loss of 0.0325 yuan [15] Group 11 - Samsung Medical's revenue for the first half of 2025 reached 7.972 billion yuan, an increase of 13.93% year-on-year [17][18] - Samsung Medical's net profit attributable to shareholders increased by 6.93% year-on-year to 1.23 billion yuan [17][18] - Samsung Medical plans to distribute a cash dividend of 4.85 yuan per 10 shares [17] Group 12 - Huiding Technology's revenue for the first half of 2025 was 2.251 billion yuan, a decrease of 0.20% year-on-year [20] - Huiding Technology's net profit attributable to shareholders increased by 35.74% year-on-year to 431 million yuan [20] - Huiding Technology plans to distribute a cash dividend of 0.15 yuan per share [20] Group 13 - Baihua Pharmaceutical's revenue for the first half of 2025 reached 202 million yuan, an increase of 2.95% year-on-year [21] - Baihua Pharmaceutical's net profit attributable to shareholders increased by 12.45% year-on-year to 25.48 million yuan [21] - Baihua Pharmaceutical's basic earnings per share were 0.0663 yuan [21] Group 14 - Stanley's revenue for the first half of 2025 was 6.391 billion yuan, an increase of 12.66% year-on-year [22][23] - Stanley's net profit attributable to shareholders increased by 18.9% year-on-year to 607 million yuan [22][23] - Stanley plans to distribute a cash dividend of 0.45 yuan per 10 shares [22] Group 15 - Duoli Technology's revenue for the first half of 2025 reached 1.734 billion yuan, an increase of 13.15% year-on-year [24] - Duoli Technology's net profit attributable to shareholders decreased by 28.13% year-on-year to 157 million yuan [24] - Duoli Technology's basic earnings per share were 0.51 yuan [24] Group 16 - Datang Telecom reported a net loss of 81.17 million yuan for the first half of 2025 [25][26] - Datang Telecom's revenue for the first half of 2025 was 275 million yuan, a decrease of 3.32% year-on-year [25][26] - Datang Telecom's basic earnings per share were a loss of 0.0623 yuan [25] Group 17 - Niuwei Co.'s revenue for the first half of 2025 reached 3.404 billion yuan, an increase of 19.96% year-on-year [27][28] - Niuwei Co.'s net profit attributable to shareholders increased by 30.44% year-on-year to 637 million yuan [27][28] - Niuwei Co. plans to distribute a cash dividend of 5.8 yuan per 10 shares [27] Group 18 - ST Zhiyun reported a net loss of 106 million yuan for the first half of 2025 [29][30] - ST Zhiyun's revenue for the first half of 2025 was 89.13 million yuan, a decrease of 63.59% year-on-year [29][30] - ST Zhiyun's basic earnings per share were a loss of 0.37 yuan [29] Group 19 - Huace Testing's revenue for the first half of 2025 reached 2.96 billion yuan, an increase of 6.05% year-on-year [31] - Huace Testing's net profit attributable to shareholders increased by 7.03% year-on-year to 467 million yuan [31] - Huace Testing plans to distribute a cash dividend of 0.5 yuan per 10 shares [31] Group 20 - Taixiang's revenue for the first half of 2025 was 219 million yuan, an increase of 6.57% year-on-year [32] - Taixiang's net profit attributable to shareholders increased by 16.12% year-on-year to 25.30 million yuan [32] - Taixiang's basic earnings per share were 0.2533 yuan [32] Group 21 - Huayi Technology applied for a credit line of up to 165 million yuan from HSBC [33][34] - Huayi Technology will use real estate as collateral for the credit line [33][34] Group 22 - Hengong Precision plans to use up to 70 million yuan of idle raised funds for cash management [35][36] - Hengong Precision will invest in high-security, high-liquidity products with a term not exceeding 12 months [35][36] Group 23 - Tianhe's financial assistance to its associate company has not been repaid [37] - Tianhe provided 243,200 yuan in financial assistance to its associate company [37] Group 24 - Spring and Autumn Electronics' revenue for the first half of 2025 reached 1.926 billion yuan, an increase of 2.62% year-on-year [38] - Spring and Autumn Electronics' net profit attributable to shareholders increased by 248.44% year-on-year to 93.31 million yuan [38] - Spring and Autumn Electronics' basic earnings per share were 0.21 yuan [38] Group 25 - Kingsoft Office's revenue for the first half of 2025 was 2.657 billion yuan, an increase of 10.12% year-on-year [39][40] - Kingsoft Office's net profit attributable to shareholders increased by 3.57% year-on-year to 747 million yuan [39][40] Group 26 - Yanjinpuzi's revenue for the first half of 2025 reached 2.941 billion yuan, an increase of 19.58% year-on-year [41] - Yanjinpuzi's net profit attributable to shareholders increased by 16.70% year-on-year to 373 million yuan [41] Group 27 - Muyuan's revenue for the first half of 2025 was 76.463 billion yuan, an increase of 34.46% year-on-year [43][44] - Muyuan's net profit attributable to shareholders increased by 1169.77% year-on-year to 10.53 billion yuan [43][44] - Muyuan plans to distribute a cash dividend of 9.32 yuan per 10 shares [43][44] Group 28 - Tianwei Food is planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange [45][46] Group 29 - Alloy Investment's shareholder plans to reduce their stake by no more than 3% [47] - Alloy Investment's shareholder plans to sell up to 11.5531 million shares [47] Group 30 - Rongzhi Rixin's controlling shareholder plans to reduce their stake by no more than 3% [48] - Rongzhi Rixin's controlling shareholder plans to sell up to 1.2318 million shares [48] Group 31 - Yijiahe's shareholders plan to reduce their stake by no more than 2% [49] - Yijiahe's shareholders plan to sell up to 409.72 million shares [49] Group 32 - Dongfeng Group adjusted the upper limit of its share repurchase price to 6.28 yuan per share [50] Group 33 - Jingu's revenue for the first half of 2025 reached 2.123 billion yuan, an increase of 10.04% year-on-year [51] - Jingu's net profit attributable to shareholders increased by 45.36% year-on-year to 30.27 million yuan [51] Group 34 - Yibai Pharmaceutical reported a net loss of 19.9 million yuan for the first half of 2025 [52] - Yibai Pharmaceutical's revenue for the first half of 2025 was 999 million yuan, a decrease of 14.99% year-on-year [52] Group 35 - Yonghui Supermarket reported a net loss of 241 million yuan for the first half of 2025 [53] - Yonghui Supermarket's revenue for the first half of 2025 was 29.948 billion yuan, a decrease of 20.73% year-on-year [53] Group 36 - Suotong Development's net profit increased by 1568.52% year-on-year to 523 million yuan [54] - Suotong Development's revenue for the first half of 2025 was 8.306 billion yuan, an increase of 28.28% year-on-year [54]

Group 1 - The core viewpoint of the news is that Samsung Medical has shown revenue growth in the first half of 2025, but its profitability is under pressure, with a reported revenue of 7.972 billion yuan, a year-on-year increase of 13.93%, and a net profit of 1.230 billion yuan, up 6.93% [1][3] - The company's profitability indicators have declined significantly, with net profit margin dropping from 16.49% to 15.24%, and gross profit margin decreasing from 34.61% to 28.97%, a decline of 5.64 percentage points [3] - The company is facing challenges in cash flow, with a negative net cash flow from operating activities of -0.059 billion yuan, compared to a positive 0.26 billion yuan in the same period last year, indicating difficulties in cash recovery [5] Group 2 - The number of institutional investors holding Samsung Medical shares has decreased dramatically from 666 to 39, reflecting a significant decline in investor confidence [7] - The company's asset-liability ratio has increased to 46.62%, up 2.92 percentage points year-on-year, indicating a heavier debt burden [5] - To reach its historical peak market value of 54.129 billion yuan, the current market value of 34.653 billion yuan would need to increase by 56.20%, highlighting the need for the company to improve operational efficiency and rebuild market confidence [7]

Group 1 - The number of shareholders in Samsung Medical increased to 29,500 as of June 30, 2025, representing a rise of 12,600 shareholders or 76.91% compared to the previous period [1] - The average number of shares held per shareholder decreased from 86,200 shares to 48,700 shares, while the average market value of shares held per shareholder dropped from 2.5494 million yuan to 1.0926 million yuan [1] - During the same period, Samsung Medical's stock price experienced a cumulative decline of 2.64% [1] Group 2 - As of the latest report, Samsung Medical's stock price is 24.66 yuan, reflecting a decrease of 2.10%, with a market capitalization of 34.653 billion yuan [2] - The changes in the number of shareholders and average holdings over the latest five reporting dates indicate a trend of increasing shareholder dispersion [3]

证券代码：601567 证券简称：三星医疗 公告编号：临 2025-064 宁波三星医疗电气股份有限公司 第六届监事会第二十次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、审议通过了关于 2025 年半年度报告及其摘要的议案 宁波三星医疗电气股份有限公司（以下简称"公司"）于 2025 年 8 月 11 日 通过书面方式发出召开第六届监事会第二十次会议通知，会议于 2025 年 8 月 21 日在公司会议室以现场结合通讯方式召开。本次会议应到监事 3 人，实到监事 3 人。会议由监事会主席郑伟科先生主持，会议的召集和召开符合《中华人民共和 国公司法》和《宁波三星医疗电气股份有限公司章程》等法律、法规及规范性文 件的有关规定。经与会监事认真审议并表决，通过了以下议案，形成决议如下： 经审核，监事会认为董事会编制和审议《三星医疗 2025 年半年度报告》及 其摘要的程序符合法律、行政法规及中国证监会的规定，报告内容真实、准确、 完整地反映了公司 2025 年半年度的经营管理情况，不存在任何虚假记载、误导 性陈述 ...

证券代码：601567 证券简称：三星医疗 公告编号：临2025-068 宁波三星医疗电气股份有限公司 关于召开2025年第二次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 股东会召开日期：2025年9月8日 ? 本次股东会采用的网络投票系统：上海证券交易所股东大会网络投票系统 一、 召开会议的基本情况 (一)股东会类型和届次 (二)股东会召集人：董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方 式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 9 月 8 日 14 点 00 分 召开地点：宁波市鄞州区首南街道日丽中路 757 号奥克斯中央大厦 25 楼会 议室 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 9 月 8 日 至2025 年 9 月 8 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 9 ...

宁波三星医疗电气股份有限公司 二〇二五年九月八日 宁波三星医疗电气股份有限公司 2025 年第二次临时股东会会议资料 宁波三星医疗电气股份有限公司 一、 主持人介绍到会股东、股东代表及代表股份数，宣布股东会开始； 二、 推举计票人、监票人，发放表决票； 三、 审议股东会议案： 宁波三星医疗电气股份有限公司 2025 年第二次临时股东会会议资料 宁波三星医疗电气股份有限公司 时 间：2025 年 9 月 8 日 14:00 地 点：宁波市鄞州区首南街道日丽中路 757 号奥克斯中央大厦 25 楼会议室 主持人：沈国英董事长 议 程： 四、 参会股东及股东代表发言或提问； 五、 现场参会股东及股东代表对议案进行投票表决； 六、 收集表决票并计票； 七、 宣布现场投票及网络投票合并后的表决结果； 八、 见证律师宣读本次股东会法律意见书； 九、 宣读股东会决议，签署会议决议等相关文件； 十、 股东会闭幕。 宁波三星医疗电气股份有限公司 2025 年第二次临时股东会会议资料 议案一： 关于为全资子公司提供担保的议案 各位股东及股东代表： 因子公司业务需要，宁波三星医疗电气股份有限公司（以下简称"公司"） 拟为南森墨西哥 ...

证券代码：601567 证券简称：三星医疗 公告编号：临 2025-067 宁波三星医疗电气股份有限公司 关于2025年半年度利润分配预案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 截至2025年6月30日，宁波三星医疗电气股份有限公司（以下简称"公司"）母 公司期末未分配利润为人民币1,592,268,983.80元。经公司第六届董事会第二十五次会 议、第六届监事会第二十次会议审议通过，公司2025年半年度拟以实施权益分派股权 登记日登记的总股本（扣除回购专用账户的股份）为基数进行现金分红。本次利润分 配预案如下： 公司拟以本次实施权益分派股权登记日登记的总股本（扣除回购专用账户的股份） 为基数，向股东每10股派发现金红利（含税）4.85元。截至本公告披露日，公司总股 本为1,405,251,200股，扣除回购专用账户股份5,755,371股，公司可参与利润分配的总 股数为1,399,495,829股，以此计算预计合计派发现金红利约人民币678,755,477.07元 （含税），占2025年半年度 ...

证券代码：601567 证券简称：三星医疗 公告编号：临 2025-063 宁波三星医疗电气股份有限公司 第六届董事会第二十五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 宁波三星医疗电气股份有限公司（以下简称"公司"）于 2025 年 8 月 11 日以 书面方式发出召开第六届董事会第二十五次会议的通知，会议于 2025 年 8 月 21 日在公司会议室以现场结合通讯方式召开。本次会议应到董事 9 人，实到董事 9 人。会议由董事长沈国英女士主持，公司监事和其他高级管理人员列席了会议。 会议的召集和召开符合《中华人民共和国公司法》和《宁波三星医疗电气股份有 限公司章程》等法律、法规及规范性文件的有关规定。经与会董事认真审议并表 决，通过了以下议案，形成决议如下： 一、审议通过了关于 2025 年半年度报告及其摘要的议案 详见公司披露于上海证券交易所网站（www.sse.com.cn）的《三星医疗 2025 年半年度报告》及报告摘要。 表决结果：9 票赞成、0 票反对、0 票弃权。 该议案已经公司审计委员会审 ...

格隆汇8月21日｜三星医疗发布2025年半年度报告，公司2025年上半年实现营业收入79.72亿元，同比增 长13.93%；实现归属于上市公司股东的净利润12.30亿元，同比增长6.93%。公司拟向股东每10股派发现 金红利4.85元（含税）。 ...